Erbitux Prices, Coupons and Patient Assistance Programs
Erbitux (cetuximab) is a member of the EGFR inhibitors drug class and is commonly used for Colorectal Cancer, Head and Neck Cancer and Squamous Cell Carcinoma.
Erbitux Prices
This Erbitux price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Erbitux intravenous solution (2 mg/mL) is around $642 for a supply of 50 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Intravenous Solution
| Quantity | Per unit | Price |
|---|---|---|
| 50 milliliters | $12.83 | $641.70 |
| 100 milliliters | $12.75 | $1,274.92 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Erbitux Coupons and Rebates
Erbitux offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Erbitux Lilly PatientOne Co-pay Program: Eligible patients may pay no more than $25 per dose with a maximum savings of up to $25,000; for additional information contact the program at 866-472-8663.
| Applies to: | Erbitux |
| Number of uses: | 12 times within calendar year |
| Expires | December 31, 2018 |
Patient Assistance Programs for Erbitux
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- Medically appropriate condition/diagnosis
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Erbitux (cetuximab)
Provider: Good Days Program
Elligibility requirements:
- Not specified
- Not disclosed
- Not specified
- US residency requirements are not specified.
- Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.
Applicable drugs:
- Erbitux (cetuximab)
Provider: Lilly Cares Patient Assistance Program-Oncology
Elligibility requirements:
- Must have no prescription coverage for needed medication
- At or below 500% of FPL
- Must be used for on-label diagnosis
- The patient must also be a US resident.
- The patient and physician must submit information to PatientOne for a benefits investigation before application will be given for the assistance program. For underinsured patients program helps connect patients with programs that can help them cover the cost of copayments and deductibles. Patients who do not have prescription insurance are reviewed for eligibility into the PatientOne patient Lilly assistance program.
Applicable drugs:
- Erbitux (cetuximab)
More about Erbitux (cetuximab)
- Erbitux Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Compare Alternatives
- Support Group
- En Español
- 8 Reviews
- Drug class: EGFR inhibitors
- FDA Alerts (1)
